|
|
||||||||||
|
J Am Coll Cardiol, 2007; 49:298-303, doi:10.1016/j.jacc.2006.10.033
(Published online 5 January 2007). © 2007 by the American College of Cardiology Foundation |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
,



,
,
* Division of Cardiology, Hartford Hospital, Hartford, Connecticut
Division of Surgery, Hartford Hospital, Hartford, Connecticut
Division of Drug Information, Hartford Hospital, Hartford, Connecticut
University of Connecticut School of Pharmacy, Storrs, Connecticut
|| University of Connecticut School of Medicine, Farmington, Connecticut.
Manuscript received July 24, 2006; revised manuscript received August 29, 2006, accepted September 11, 2006.
* Reprint requests and correspondence: Dr. Jeffrey Kluger, Heart Rhythm Service, Hartford Hospital, 80 Seymour Street, Suite 1001, Hartford, Connecticut 06102-5037. (Email: jkluger{at}harthosp.org).
OBJECTIVES: We conducted a randomized, blinded, controlled study evaluating the impact of anterior fat pad (AFP) maintenance on postoperative atrial fibrillation (POAF) incidence.
BACKGROUND: Drugs with antiadrenergic effects reduce POAF. Because the epicardial AFP is parasympathetically innervated, its routine excision during coronary artery bypass grafting (CABG) might precipitate autonomic imbalance and induce POAF.
METHODS: Patients (n = 180, mean age = 66 ± 10 years, 80% men, 5% with previous atrial fibrillation) undergoing CABG surgery were randomized to either AFP maintenance or AFP removal. Routine prophylaxis against POAF with beta-blockers (85%) and amiodarone (28%) was allowed on the basis of caregivers discretion. The development of POAF, total hospital costs, and heart rate variability was compared between groups.
RESULTS: Anterior fat pad maintenance did not reduce POAF incidence (34.8% vs. 35.2%, p = 0.950) or total hospital costs (data as medians with 25%, 75% percentiles: $22,940 [$17,629, $29,274] vs. $23,866 [$18,602, $30,370], p = 0.647) but was associated with higher heart rate variability (SD of normal-to-normal RR intervals [SDNN]: 31.7 ± 24.6 vs. 22.7 ± 8.3, p = 0.05 and SD of all 5-min mean RR intervals [SDANN 5]: 17.1 ± 11.9 vs. 10.1 ± 5.5, p = 0.003) than AFP removal.
CONCLUSIONS: Maintaining the AFP prevents attenuation of parasympathetic tone after CABG but does not reduce POAF or total hospital costs in any appreciable way.
| ||||||||
This article has been cited by other articles:
![]() |
K. Lertsburapa, C. M. White, J. Kluger, O. Faheem, J. Hammond, and C. I. Coleman Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 405 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Arora, J. S. Ulphani, R. Villuendas, J. Ng, L. Harvey, S. Thordson, F. Inderyas, Y. Lu, D. Gordon, P. Denes, et al. Neural substrate for atrial fibrillation: implications for targeted parasympathetic blockade in the posterior left atrium Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H134 - H144. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. White, J. Kluger, K. Lertsburapa, O. Faheem, and C. I. Coleman Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 817 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L Baker and C M. White Post-Cardiothoracic Surgery Atrial Fibrillation: A Review of Preventive Strategies Ann. Pharmacother., April 1, 2007; 41(4): 587 - 598. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |